Interferon-stimulated gene 15 enters posttranslational modifications of p53

Area of Science:

• Molecular Biology
• Cellular Biology
• Oncology

Background:

• The tumor suppressor protein p53 regulates cellular signals, with its activity controlled by ubiquitination and ubiquitin-like (UBL) modifications.
• Interferon-stimulated gene 15 (ISG15) is a UBL protein with diverse functions, including roles in antiviral responses, autophagy, DNA repair, and protein translation.
• While the link between ISG15 and p53 is known, the functional outcomes of p53 ISGylation are not fully understood.

Purpose of the Study:

• To summarize current knowledge on p53 ISGylation.
• To differentiate p53 ISGylation from other significant p53 modifications.
• To provide insights beneficial for developing p53-based cancer therapies.

Main Methods:

• Literature review and synthesis of existing research on p53 modifications.
• Comparative analysis of ISGylation with ubiquitination and other UBL modifications of p53.
• Identification of potential therapeutic implications based on current understanding.

Main Results:

• ISG15 conjugation to p53 (ISGylation) is a critical regulatory mechanism.
• p53 ISGylation's functional consequences are complex and require further elucidation.
• Interactions between p53 ISGylation and other modifications like ubiquitination are increasingly recognized.

Conclusions:

• Understanding p53 ISGylation and its interplay with other modifications is crucial for advancing cancer therapy.
• Further research into p53 ISGylation pathways may reveal novel therapeutic targets.
• Clarifying these modifications can enhance the efficacy of p53-targeting cancer treatments.